These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 13175188)

  • 41. [On the monitoring of neuromuscular blockade during anaesthesia (author's transl)].
    Schuh FT
    Anaesthesist; 1977 Mar; 26(3):107-15. PubMed ID: 857689
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Histamine liberation by neuromuscular blocking agents.
    MACMILLAN WH; GIARMAN NJ
    Am J Physiol; 1955 Oct; 183(1):9-11. PubMed ID: 13268626
    [No Abstract]   [Full Text] [Related]  

  • 43. Muscle relaxants in infants and children.
    Cook DR
    Anesth Analg; 1981 May; 60(5):335-43. PubMed ID: 6261612
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of prior administration of a non-depolarising muscle relaxant on the action of suxamethonium in the dog.
    Jones RS; Gleed RD
    Res Vet Sci; 1984 May; 36(3):348-53. PubMed ID: 6463378
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The interaction of benzoquinonium and other neuromuscular blocking agents.
    HOUGS W; JOHANSEN SH
    Acta Pharmacol Toxicol (Copenh); 1958; 14(4):385-9. PubMed ID: 13594501
    [No Abstract]   [Full Text] [Related]  

  • 46. The quest for a short-acting nondepolarizing neuromuscular blocking agent.
    Savarese JJ; Kitz RJ
    Acta Anaesthesiol Scand Suppl; 1973; 53():43-58. PubMed ID: 4139860
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of some neuromuscular blocking agents on mitochondrial enzyme systems.
    KOCH JH; GALLAGHER CH
    Nature; 1959 Oct; 184():1039-41. PubMed ID: 14410326
    [No Abstract]   [Full Text] [Related]  

  • 48. Relation of benzoquinonium to other neuromuscular blocking agents.
    HOUGS W; JOHANSEN S
    Acta Pharmacol Toxicol (Copenh); 1957; 13(4):410-9. PubMed ID: 13444003
    [No Abstract]   [Full Text] [Related]  

  • 49. [Pharmacological studies on bisatropinium bromide, a new muscle relaxant].
    Chen GK; Fang RY; Zhang YP
    Yao Xue Xue Bao; 1984 Jan; 19(1):21-7. PubMed ID: 6477678
    [No Abstract]   [Full Text] [Related]  

  • 50. [The response of the external eye muscles to curare, decamethonium and succinylcholine].
    HOFMANN H; LEMBECK F
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1952; 216(6):552-7. PubMed ID: 13036921
    [No Abstract]   [Full Text] [Related]  

  • 51. Effects of decamethonium (C-10) on the neuro-muscular junction of soleus in the cat.
    HUIDOBRO F
    Acta Physiol Lat Am; 1955; 5(1):1-9. PubMed ID: 14398303
    [No Abstract]   [Full Text] [Related]  

  • 52. Study on the central action of neuromuscular blocking agents.
    SAKUMA A
    Jpn J Pharmacol; 1959 Sep; 9():30-40. PubMed ID: 14440879
    [No Abstract]   [Full Text] [Related]  

  • 53. Electromyographic study of differential sensitivity to succinylcholine of the diaphragm, laryngeal and somatic muscles: a swine model.
    Lu IC; Wang HM; Kuo YW; Shieh CF; Chiang FY; Wu CW; Tsai CJ
    Kaohsiung J Med Sci; 2010 Dec; 26(12):640-6. PubMed ID: 21186012
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nitroglycerin and the neuromuscular blockade produced by gallamine, succinylcholine, d-tubocurarine, and pancuronium.
    Glisson SN; Sanchez MM; El-Etr AA; Lim RA
    Anesth Analg; 1980 Feb; 59(2):117-22. PubMed ID: 6768318
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of hypercarbia on the activity of neuromuscular blocking agents in the cat.
    JOHANSEN SH; OSGOOD PF
    Acta Pharmacol Toxicol (Copenh); 1962; 19():212-8. PubMed ID: 13957827
    [No Abstract]   [Full Text] [Related]  

  • 56. [Depolarizing effect of acetylcholine in the activity of neuromuscular blocking agents. (Review of the literature)].
    BRISKIN AI
    Farmakol Toksikol; 1961; 24():499-507. PubMed ID: 13873157
    [No Abstract]   [Full Text] [Related]  

  • 57. [Mechanism of the action of myorelaxants].
    Beloiartsev FF; Khmelevskiĭ IaM
    Eksp Khir Anesteziol; 1972; 17(2):85-8. PubMed ID: 4261519
    [No Abstract]   [Full Text] [Related]  

  • 58. Neuromuscular blocking agents. IX. Some short-acting linear NNN-tris-onium esters.
    CAREY FM; LEWIS JJ; STENLAKE JB; WILLIAMS WD
    J Pharm Pharmacol; 1961 Dec; 13(Suppl)():103-6. PubMed ID: 13876563
    [No Abstract]   [Full Text] [Related]  

  • 59. Comparison of the pharmacology and vecuronium and atracurium with that of other currently available muscle relaxants.
    Hilgenberg JC
    Anesth Analg; 1983 May; 62(5):524-31. PubMed ID: 6132564
    [No Abstract]   [Full Text] [Related]  

  • 60. Electrocortical synchronization resulting from reduced proprioceptive drive caused by neuromuscular blocking agents.
    HODES R
    Electroencephalogr Clin Neurophysiol; 1962 Apr; 14():220-32. PubMed ID: 13907942
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.